Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Medis Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1052)
ARTG (149)
Cancellation or suspension (26)
Listed medicine compliance report (5)
Prescription medicine registration (2)

Date

2024 (866)
2023 (3)
2022 (29)
2021 (106)
2020 (31)
2019 (6)
2018 (6)
2017 (47)
2016 (5)
2015 (29)
2014 (29)
2013 (29)
2012 (23)
2011 (12)
2010 (3)
2009 (8)
2008 (1)
1993 (1)

Results for "[search-keyword]"

Search

Sponsor content

1234 result(s) found, displaying 821 to 830

LAMOTRIGINE-AS lamotrigine 50 mg dispersible/chewable tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
LAMOTRIGINE-AS lamotrigine 25 mg dispersible/chewable tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
FLUOXETINE-AS fluoxetine hydrochloride 20mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
LISINOPRIL HEXAL lisinopril 20mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
LISINOPRIL HEXAL lisinopril 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
LISINOPRIL HEXAL lisinopril 5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
LIPRACE lisinopril 20mg tablet bottle Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
LIPRACE lisinopril 10mg tablet bottle Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
LIPRACE lisinopril 5mg tablet bottle Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
LIPRACE lisinopril 5mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

7 June 2024

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd

Pages

First page
Previous page
…
Page 79
Page 80
Page 81
Page 82
Current page 83
Page 84
Page 85
Page 86
Page 87
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.